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Abstract
Incidence of insulin resistance continues to grow, becoming a major public health con‐
cern worldwide. Besides the classical risk factors (obesity, unhealthy nutrition and lack 
of exercise), extensive research about some occupational hazards supports their asso‐
ciation with insulin resistance and metabolic syndrome. On the one hand, the classical 
risk factors for insulin resistance are augmented by the changes of the working condi‐
tions: the occupational level of physical activity has a tendency to decrease, reducing its 
contribution to the overall level of physical activity and favouring a sedentary lifestyle 
and the occupational stress became the second most common work‐related health issue, 
contributing to the increase of the maladaptive habits, such as unhealthy nutrition. On 
the other hand, some insulin resistance risk factors are primarily occupational hazards: 
desynchronization of the circadian rhythm and sleep disruption during the night shifts, 
workplace air pollution (particles, solvents), heavy metals (arsenic, mercury) or persis‐
tent organic pollutants exposure. Meantime, workplaces are excellent settings for health‐
promotion programmes and metabolic risk reduction, if there is managerial commitment 
and support. Therefore, assessment of the risk, screening and workplace intervention 
programmes to reduce insulin resistance incidence should be included in the occupa‐
tional health service provision.
Keywords: insulin resistance, occupational stress, sleep desynchronization, night shifts, 
sleep duration, indoor air pollution, persistent organic pollutants arsenic, mercury
1. Introduction
Insulin resistance (IR) is a complex pathophysiological state characterized by reduced target 
cells responsiveness to insulin. The variety of its manifestations correspond to the complex‐
ity of insulin actions in specific tissues; the IR state reduces glucose uptake in muscle and 
other insulin‐dependent tissues, increases lipolysis and fatty acids delivery from adipose tis‐
sue, increases hepatic glucose output and sodium retention, impairs uric acid metabolism, 
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enhances vascular endothelium vasoconstriction and inflammation—promoting atherosclero‐
sis and induces a systemic low grade metabolic inflammation. Two are the major clinical con‐
sequences of the IR: the cardio‐vascular disease and diabetes. There are also significant links 
between IR and other clinical conditions such as non‐alcoholic fatty liver disease, polycystic 
ovary syndrome and colorectal cancer. Cardiovascular diseases are already the leading cause 
of death in industrialized countries [1] and diabetes prevalence has doubled between 1980 and 
2014. Diabetes is estimated to become the seventh leading cause of death in 2030 [2]. Taken 
together, all medical conditions related to IR are responsible for a high percentage of the total 
mortality rate. Therefore, prevention and early diagnosis is a major public health topic.
For many years, IR has been considered a complication of obesity but a non‐obese metabolic 
obese profile has been identified in the past few years, as up to 15–30% of the IR subjects are 
in the normal range value of the BMI. The complex pathogeny of IR has been explained by 
complementary or synergic interactions between genetic and epigenetic factors, gut microbiota 
and environmental factors. As the environmental factors are the modifiable ones, the interven‐
tion, including workplace interventions, became nowadays a major health prevention direction.
Insulin resistance is difficult to measure in clinical practice; therefore, surrogates are used 
for its assessment such as basal insulinemia, the homeostasis assessment index (HOMA‐IR), 
glucose ratio to insulin and the glucose tolerance test. Clinical markers for IR are lipid metab‐
olism impairment (increased triglycerides, reduced HDL cholesterol and increased LDL 
cholesterol), plasma uric acid increase, renal disease markers (albuminuria) and cardiovas‐
cular effects (hypertension and cardiac remodelling). As already mentioned, obesity, particu‐
larly the visceral deposition of the adipose tissue, is a risk factor. In different configurations, 
according to different scientific organizations, these factors define the metabolic syndrome, a 
more suitable clinical diagnostic. Although I fundamentally agree with those considering that 
metabolic syndrome is an ‘artificial syndrome’—in fact is just a cluster of risk factors—and 
that diagnostic procedures should be developed for an easier clinical diagnostic of the IR 
syndrome, this article will have to rely on data accumulated under the metabolic syndrome 
entity, as it is much more frequently used in the medical literature.
Nutrition, lack of physical exercise are not occupational hazards that are traditionally IR risk 
factors. In recent research, there is more and more evidence accumulated on how particular occu‐
pational risks are involved in IR and this makes the subject of increasing interest for occupational 
physicians.
2. Epidemiological arguments
An impressive number of studies have emphasized that risk factors for cardiovascular and 
diabetes are more prevalent in low‐educated, low‐income population [3–8], particularly 
related to the high incidence of the negative health habits (smoking, drinking, high fat or 
low fruit diet [8]). Being a member of a low social class during childhood [9] also favoured 
unhealthy‐related behaviours: low level of sport practice, high fat diet, emotional stress and 
material unfavourable conditions. In different cohorts, significant differences between men 
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and women [6, 7] were found, which could not be fully explained by sexual level of hormones. 
Marital status [5] in men appeared to have different influences in developing countries com‐
pared to the developed ones: a high risk factor in developing countries and a low risk factor 
in western countries [4]. The high prevalence in developing countries has been explained by 
cultural habits such as accessibility to eat out or practice outdoor physical activities and less 
concern about gaining weight. In women, marital status in western countries is associated 
with an increased risk.
In the early years of socio‐economic development, the changing habits represent a risk fac‐
tor for IR [10, 11]. The theory of epidemiological transition states that, under development 
conditions, there is a switch between mortality dominated by infectious diseases to mortality 
related to degenerative and man‐made diseases [12]; conditions related to IR fill in this cat‐
egory, reflecting changes in nutrition and transition from physical activity to sedentariness 
[11]. In these countries, at the beginning of the development era, the high income class has 
higher risk [5], as it has access to more resources, moves to more sedentary lifestyle and tries 
to compensate all childhood economical disadvantages and frustrations accumulated.
Even if there are differences according to the socio‐economic development period the country 
is passing by, there are also many similarities. For example, a comparison between Taiwan and 
US revealed interesting similar inflammation scores (serum IL‐6, CRP, fibrinogen, sICAM‐1, 
sE‐selectin and sIL‐6R), cardiovascular risk factors (systolic and diastolic blood pressure, total 
cholesterol, HDL cholesterol, triglycerides, glycosylated haemoglobin, BMI, waist‐hip ratio 
and resting pulse) and hypothalamic‐pituitary‐adrenal axis and sympathetic nervous system 
function (epinephrine, norepinephrine, DHEAS and urinary cortisol) in relation to the socio‐
economic status [13].
Occupation and employment status are major determinants of the economical welfare and unem‐
ployment has been linked to metabolic risk in both developed and in under development 
countries [4, 5, 14]. There is difficult to find common grounds for data reported from different 
countries, as occupations are differently coded and registered: an US countrywide survey found 
maximum incidence of risk factors in the farm industry (operators, managers and supervisors), 
in food preparation and food services, motor vehicle operators and among administrative staff 
(secretaries, stenographers and typists), and the lowest in professional specialties (particularly 
in writers, artists, entertainers and athletes) [15]. Several studies have classified occupations in 
manual (blue collars) and non‐manual (white collars, office workers) activities and found either 
increased or a decreased incidence of metabolic syndrome components in manual workers [16, 
17]. These differences were most probably related to the confounders not included in these stud‐
ies, such as nutrition, smoking, alcohol and level of occupational physical activity.
There are many limitations of these epidemiological studies for a direct application in the 
occupational physician practice, although the prevalence and social risk factors are important. 
They give a broader perspective for any intervention proposed. The epidemiological transi‐
tions reflect the major trends and do not provide specific information by industry. As far as 
working conditions are concerned in the transitional period, the main negative factors are the 
unbalanced working hours to leisure activities, the increased number of jobs with sedentary 
activity and the increased amount of perceived stress.
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3. Occupational hazards
3.1. Sedentary lifestyle
The link between inactivity and insulin resistance has been documented for many years 
and extensive experimental and clinical research have clarified this relationship in detail. 
Currently, an inactive person is defined by having less than 30 min/day of at least moderate 
level of activity, either as occupational or as leisure time activity. As the occupational activi‐
ties become less physical demanding, it would be reasonable to compensate by more physical 
activities such as sports practice, gardening and brisk walking [18] instead of increasing the 
number of hours of TV watching or computer interactions, as we see as a trend nowadays [19]. 
It is estimated that only 20% of currently industrial jobs demand an average level of physical 
activity, with a reduction of more than 100 kcal/day in energy expenditure since 1960 [18].
Benefits of exercise in metabolic regulation: Glucose is transported into muscle cell by facilitated 
diffusion through GLUT4 and GLUT1 channels; GLUT4 is the major transporter. In resting 
conditions, GLUT4 is located intracellularly and its traffic to the membrane is insulin medi‐
ated. Inside the muscular cell, glucose is phosphorylated to glucoso‐6‐phosphate (G‐6P), a 
compound that cannot transfer outside the cell. During a rest, it is stored as glycogen and 
during exercise it takes the glycolytic pathway. During exercise, the blood flow increases, thus 
increasing the amount of glucose available; this creates a gradient for glucose to entry the cell. 
As cells utilize energy for sustaining muscular contraction, the ratio of AMP/ATP increases, 
activating the AMP‐activated protein kinase (AMPK). This kinase is able to enhance the trans‐
port of GLUT4 to the membrane in an independent insulin manner. AMPK activity is also 
increased by leptin, through indirect hypothalamic action and adiponectin, by a direct action. 
In obesity, resistance to leptin diminishes AMPK activity [20]. Exercise increases GLUT4 
transport and fatty acid oxidation, improving insulin sensitivity. Acute changes depend on 
the energy balance: if this is positive, the carbohydrate oxidation will prevail and if it is nega‐
tive, the fatty oxidation will be enhanced [20]. In order to reduce fatty mass, a negative balance 
is also requested. The type of exercise also influences the energy substrate utilization: endur‐
ance training increases fatty acid oxidation while resistance training, increases glucose uptake 
and utilization; most probably, this is due to the increase in muscular mass [21]. Lipoprotein 
lipase increases after training and maintains a higher level afterwards; the higher the level of 
exercise, the longer will be the duration of the high level of lipoprotein lipase and the pre‐
ventive action. Chronic training contributes to increase the number of myofibrils and their 
oxidative capacity. Training has also a role in restoring mitochondrial content in ageing popu‐
lations or in different pathological conditions [22–25] and in activating satellite cells [26]. The 
mitogenesis effect increased with 25% when calorie restriction was associated [27]. In previ‐
ous sedentary obese men and women, training increased the mitochondrial electron transport 
and decreased IR.
Exercise partially counteracts other risk factors, such as a fatty diet. High lipid intake increases 
the fatty acids content in muscular cells, β‐oxidation, acetilCoA level, NADH/NAD ratio 
(slowing of tricarboxylic acid cycle) and leads to citrate accumulation. Citrate inhibits muscle 
hexokinase and reduces the formation of glucoso‐6‐phosphate; the glucose traffic through 
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GLUT4 channels is, therefore, reduced, contributing to chronic hyperglycaemia. This pro‐
cesses favours fatty acid utilization and counteracts the insulin metabolic switch. A vicious 
pathological cycle is created between decreased sensitivity of GLUT 4 and reduced uptake 
of glucose. Some benefits of exercise are explained by disrupting this cycle. Training even 
reversed the other negative risk factors, such as obesity influence or small size at birth [28].
Relationship between sedentary lifestyle and obesity: Sedentary lifestyle infers a low energy expen‐
diture that should be adjusted by a balanced reduction in food intake, but food intake is 
driven by many other factors compared to expenditure in abundant, accessible nutrient soci‐
eties. In such context, calorie intake becomes easy and higher than requested for thermo‐
regulation and metabolic purposes. In a strict mathematical formula, this will lead to increase 
in body weight. High calorie intake is a consequence of high fat and/or high‐carbohydrate 
diets. Randle's hypothesis of fatty acid toxicity [29] is a classical explanation of IR induction 
by excessive fatty diets. High circulating level of fatty acids inactivates insulin cellular signal 
and impairs the switching of the metabolism from fatty acids to glucose, with progressive 
accumulation of intra‐cytoplasmic lipids in insulin sensitive cells (including β‐cells); the lipid 
accumulation, mainly of ceramides, induces apoptosis. In muscular cells, the increased level 
of fatty acids inhibits phosphorylation of insulin receptor substrate 1 and activation of phos‐
phoinositol 3 kinase, with a decrease in glycogen storage. High carbohydrate diets, particu‐
larly of those with high glycaemic index, desensitise glucose receptors and increase oxidative 
stress on β‐cells that ultimately lead to insulin depletion. High fructose intake feeds the glu‐
coneogenesis and the lipogenic pathways [30] in hepatic cells and by depleting the cellular 
ATP content and gives to the brain a signal of energy deprivation, favouring food seeking 
behaviour. Increased hepatic glucose output maintains a hyper‐insulinemic state with higher 
fat storage in adipose tissue.
Sedentary life decreases the proportion between the fat mass and the free fat mass. According 
to the energy balance concept, it would be expected, as the total body mass increases, that the 
total energy consumption increases, from the basal metabolism increase. The energy expendi‐
ture is dominated (with exception for highly competitive professional athletes) by the resting 
metabolic rate and the variation in size of the free fat mass that explains 60–80% of the varia‐
tion in basal metabolism [31], with an approximated 5:1 ratio between free fat mass and fat 
mass [32]. Energy balance is a remarkable concept, but cannot fully explain the complexity of 
the metabolism regulation and of the metabolic flexibility, governed by insulin. In sedentary 
adult with positive energy balance, the proportion of fatty mass increases gradually; even if 
the adjusted increase of the basal metabolic rate would be proportionate with the total mass, 
this increase will not compensate the level of calories intake, because fat mass has lower basal 
metabolism than skeletal muscle and fat will continue to accumulate. Obesity, as defined by a 
quantitative increase of fat tissue or as proportion between fat mass and fat free mass [33], is a 
direct consequence. The abnormal proportion and not the BMI is, in fact, related to the meta‐
bolic risk factors. This explains, at least partially, the cardio‐metabolic risk of the non‐obese 
metabolically obese population. This increase in quantity is also associated with qualitative 
impairments, a phenomenon described as adiposopathy or ‘sick fat’ [34]. The increased level 
of leptin and of other inflammatory cytokines, the decreased level of adiponectin, switch of 
the macrophages to the M1 pattern and to a pro‐inflammatory status and lower capacity of 
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oxidizing fat are the main characteristics of the metabolic pattern of adiposopathy. Muscle is 
the main consumer of glucose and fatty acids and by that, the major contributor to the low‐
ering of glucose and of the fatty acid plasma levels; if free fat mass (mainly muscle mass) is 
reduced due to the sedentary lifestyle, the risk of adiposopathy increases.
Occupational level of physical activity has a general tendency to decrease. This reduction in 
contribution to the overall level of physical activity explains that a significant IR risk was 
associated with leisure time sedentary behaviour but not with occupational activity in gen‐
eral population [35]. However, when looking more closely, it becomes obvious that several 
professions are at higher risk: for example, VDU operators in call centres [36] or bus drivers 
[37] had a higher OR for metabolic syndrome, after confounders such as smoking or leisure 
time activity were excluded. Comparison of sedentary lifestyle has been highly suggestive 
between different professions and even among same profession that has specificities accord‐
ing to national regulations: for example, police officers and administrative clerks have the 
higher risk than fire fighters in states where training programmes are strictly supervised but 
not in voluntary forces (US) [38].
During work, the sedentary activity can be more sustained (more than 30 min) than during 
non‐working hours and this has also an impact [39]. Beneficial effects in adiposity measures, 
triglycerides and 2‐h plasma glucose were obtained even in sedentary persons with more 
interruptions in sedentary time [40].
Sitting for more than 1 h reduces the lipoprotein lipase activity [41] and the non‐exercise 
activity thermogenesis [42]. Adjustable workstations might be a solution for prolonged sitting 
activity. In a recent systematic review, the majority of prospective studies found that occupa‐
tional sitting was associated with a higher risk of diabetes and mortality and to some degree 
of cardiovascular risk. These apparent conflicting results between the two consequences of 
the IR could be related to the heterogeneity of study designs and to the inconsistency and 
sufficiency of data recorded on overall physical activity. Possible other confounders are diet, 
tobacco, alcohol and high energy food consumption, as sitting for long hours increases the 
chance of negative habits to develop. When the total physical activity was considered, the 
association between sitting and metabolic risk lost the statistical significance [43].
Clinical approach: Clinical evaluation of the physical activity is rather easy and should be 
part of the routine examination. BMI is also very frequently recorded and, even if it has the 
above‐mentioned limitations, it has an orientation value. In order to be more specific about 
the metabolic risk, abdominal circumference could be added to the physical examination, 
particularly to the non‐obese persons, defined by the BMI index. More accurate data about fat 
mass proportion are obtained by bioelectrical impedance analysis, but they are not used in 
routine clinical examinations.
As high physical activity has numerous benefits, it should be encouraged to everyone, 
according to its age, health status and preferences. There is enough evidence that even small 
increases, if they are sustained and become part of the routine, have high medium‐term 
impact as primary or secondary preventive measures. If sitting is the main problem, an ergo‐
nomic intervention could be beneficial.
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3.2. Sleep and night shifts
Sleep duration and sleep architecture are important indicators of individual health. When 
normal sleep is impaired, alertness, memory, learning, thermoregulation, respiratory, meta‐
bolic and cardio‐vascular regulation are also disturbed. This broad spectrum of effects is one 
of the consequences of the complex connections between the hypothalamic clock and dif‐
ferent nuclei in the central nervous system [44] and of the interaction between the central 
and the peripheral circadian regulators. Assessing sleep duration, sleep‐wake cycle and sleep 
disorders in the occupational medical practice is very important, because they influence sig‐
nificantly the fitness for work particularly in high risk jobs for accidents (professional driving, 
traffic controllers, working at height, etc.).
Normal sleep regulation: Sleep onset and duration are the core elements of sleep‐wake regula‐
tion. Sleep‐wake regulation is currently explained by two biological models: the sleep homeo‐
stasis and the circadian clock. Sleep homeostasis refers primarily to the variation of sleep 
pressure, while the circadian clock concerns the activity of the hypothalamic pacemaker, act‐
ing independently of the prior sleep period [45]. Although interrelated, their regulation path‐
ways are different: sleep pressure is mainly dependent on the existing sleep debt and is the 
physiological contributor to the recuperation of this debt. If during the previous day the sleep 
duration was shorter, the sleep homeostasis will intervene to correct the deficit.
The pacemaker of the clock automatism is genetically set to a circadian rhythm and is con‐
trolled by the environmental factors. The circadian period (the interval that covers a full cycle 
of sleep‐wake, not influenced by external constraints) is the tau; tau varies in healthy individu‐
als between 24 and 25 h and reflects the automatism of the suprachiasmatic nuclei processes 
(is circadian clock dependent). In healthy adult individuals, periodicity of sleep duration 
waxes and wanes ranges broadly (around 2–18 days), indicating that for a specific individual 
the number of hours slept varies in consecutive days, having a repetitive pattern of duration. 
For example, for the 5 days pattern, the number of hours slept in day 1 is the same as the 
one in day 6; between day 1 and day 6 there is an increase and then a decrease in duration of 
sleep. This inter‐individual variation is determined by the different build up sleep pressure in 
healthy individuals and is dependent primarily to the sleep homeostasis. This variance will 
impact on different ways the adaptation to night shifts and to longer working hours of differ‐
ent individuals.
Under a certain extent, the clock is self‐regulated by its genomic functionality. The activation 
of the hypothalamic neurons starts with the transcription of the Clock and Bmal 1 genes that 
have circadian variations, related to day‐night transitions; their products form a heterodimer 
(CLOCK‐BMAL1) that binds to the promotion site of Period 2 (Per2), Cryptochrome (Cry). The 
cytoplasmic levels of PER2 and CRY regulate the transcription induced by CLOCK‐BMAL1 
heterodimer through a negative feedback loop. Besides this auto‐regulated feedback loop, 
Clock and Bmal1 are also influenced by a secondary control loop, acting on two nuclear recep‐
tors, the Retinoid‐related orphan receptor (Ror) and the Rev‐Erb receptor. While Ror is a transcrip‐
tion activator, Rev‐Erb is an inhibitor one [46]. PER and CRY reach a maximum at the normal 
transition from day to night maintaining the negative feedback loop of the clock and contrib‐
uting to the sleep onset. BMAL1 reaches the maximum at the transition from day to night, at 
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waking time. In order to generate the level of BMAL1 requested for waking, ROR and REV 
ERB maxima occur between that of BMAL1 and PER‐CRY.
Dark is the physiological stimulus of melatonin, although melatonin increases during the 
evening even in blind persons [47]. While its major role is to induce sleep, melatonin has also 
other functions such as heat loss or glutathione synthesis inducer [48]. It also influences the 
immune response and the glucose metabolism.
Sleep cycles have normal variation during the night: in the first part of the night, there are 
more non‐rapid eye movement (NREM) periods than in the last part; stage 1 of sleep dimin‐
ishes (in percentage time of the total cycle) in the second part of the night and stage 1 is no 
more present after the first 4 h of night sleep. During nightshifts or sleep interruptions, the 
normal sleep architecture is modified and explains the tiredness people feel, after a working 
night, even after an equal number of hours of recovery sleep.
Normal sleep duration: A large European study revealed significant differences between coun‐
tries, related mainly to cultural habits than to environmental ones (sunlight or temperature 
variation) as winter and summer sleep duration showed no significant variation by country 
[49]. On average, adults sleep 7–7.5 h/night [50]. In adults, adjusted prevalence of short sleep‐
ers (<5–6 h/night) or long sleepers (>10 h/night) is 0.52 and 0.64%, respectively [51]. Duration 
of sleep is influenced by genetic, personality traits and social habits. Long sleepers had higher 
neuroticism scores and lower education levels than short sleepers [51, 52]. Short sleepers are 
more frequent in adults that have not sleep alone in their childhood, as toddlers or pre‐school‐
ers [52]. Familial nocturnal short sleepers have been identified in a mutation on the gene 
DEC2: in persons caring this mutation, the whole duration of sleep in 24 h is less than 6 h 
[53]. Shorter sleeping time was associated with the total time spent sitting and with increased 
screen time in a large cross‐sectional European survey [54], linking this risk factor with sed‐
entary lifestyle and with a long time of computer interaction.
Metabolic effects related to sleep regulation: Hypothalamic clock does not regulate just the sleep‐
wake status; it is the central driver for the peripheral clocks correspondents in colon, stom‐
ach, pancreas, liver, adipose tissue and muscles: through this integration, certain metabolic 
pathways have circadian fluctuation. It is estimated that 10–15% of the gene transcripts have 
rhythmically 24‐h cycles; besides the genes expression, translational changes have also cir‐
cadian fluctuations. There is a normal variation of the peak transcripts during day (e.g. pro‐
teins involved in inflammation and hormonal response) or night (e.g. proteins involved in 
ribosomal and epigenetic processes such as methyltransferases) [55]. In twin‐based genetic 
studies, heritability is found responsible for 33–55% of the sleep duration; interestingly, heri‐
tability influence increases when twins are living together for a longer period in their life [56].
Besides the central clock influence, there is also an intrinsic circadian variance of the meta‐
bolic genes, as response of the Clock/Bmal1 or Per 2 variation of expression. All hormones 
involved in glucose regulation (cortisol, catecholamine, glucagon and insulin) have circadian 
peaks. There is significant increase in insulin sensitivity during the early nocturnal sleep and 
a returning to the pre‐sleep values during the late phase of the sleep [57]. In animal studies, 
melatonin decreases insulin and increases glucagon secretion in pancreatic cells; high insulin 
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levels, as reached in type II diabetes, decrease the melatonin level [58]. In humans, several 
genetic polymorphisms of the melatonin gene are risk factors for IR. A later rise of the morn‐
ing melatonin peak is encountered in persons with the GG allele of the melatonin gene and 
this time corresponds to the usual timing for food intake. The later than normal melatonin 
raise deregulates glucose metabolism, as it counteracts the nutrient‐related signals transmit‐
ted to the pancreas cells. Other genetic variants, as the MTNR1B gene variant, increase the 
number of melatonin receptors expressed by β‐cells with negative impact on the insulin secre‐
tion. Subjects carrying this allele, receiving 4 mg melatonin/day, had, after 3 months of treat‐
ment, significantly less insulin secretion and were more IR than controls [59]. Possible future 
testing of these genomic characteristics will allow occupational physicians to distinguish the 
persons that will have more difficulties in adapting to working in shifts and those that are at 
risk of developing metabolism disturbances, including IR.
Negative influences of work schedule on insulin resistance
1. Short sleep duration. Short‐term sleep loss could be perceived as a metabolic stressor: it 
increases metabolism but also the anti‐oxidant capacity [60]. These adaptations are sur‐
passed in sleep deprivation, when major disturbances in hormonal regulation occur. 
Glucagon and cortisol are lower after a night of sleep deprivation [61]; there is also a lower 
response in adrenaline to hypoglycemia, explaining both the hunger and the fatigue syn‐
drome in the day after. The day after sleep deprivation is characterized by both autonomic 
symptoms (anxiety, sweating, irritability, hunger) and glycopenic symptoms: dizziness, 
blurred vision and difficulty in thinking. After four nights of sleep deficit, the insulin sig‐
nal pathway was reduced by 30% in adipocytes [62]. Cortisol levels increase just after one 
night of sleep deprivation. Even if the glucose tolerance tested by I.V. glucose tolerance 
test was similar with the reference group, the short sleepers had a reduction by 40% of 
the insulin sensitivity, both in the first and in the second phases of response [63]. Another 
strong argument of the influence of sleep on the IR is the reduction of HOMA‐IR after an 
increase of amount of time slept by 45 min/night, a rather cost‐effective intervention for 
prevention of IR [64].
The work time arrangements are very important for maintaining a physiological recovering 
sleep. Increased risk for metabolic syndrome was not constantly found in relation to working 
in shifts. However, alterations in glucose and lipid metabolism, observed in experimental set‐
tings [65, 66] of night shifts combined with a total reduction on sleeping hours (less than 5 h/
day) and adverse nutritional habits [67] significantly increase the risk.
2. Desynchronization of the circadian rhythm. Another consequence of working in shifts is 
the shifted circadian rhythm (desynchronization, misalignment). The desynchroniza‐
tion increases the effects of sleep deprivation; the insulin sensitivity is twice reduced if 
restriction is combined with 8.5 sleep delay (circadian misalignment). After 10 days of 
longer day duration (duration of 28 h) a significant increase of glucose, decrease of leptin, 
reversed cortisol cycle and an increase of mean arterial pressure [68] have been recorded. 
A decrease in insulin sensitivity and leptin secretion are also common [69].
The metabolic effects of the desynchronization on the circadian rhythm have been ex‐
plained by the conflict between the disturbed circadian variations of the peripheral clocks 
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and the feeding stimulus. In general, peripheral clock shifts at a slower rate than the cen‐
tral clock. The circadian variation of different peripheral factors involved in metabolism 
regulation such as adipokines [70], pancreatic secretions, PPARγ PGC1α is supported by 
numerous experiments. Besides this circadian variation, their expression is also triggered 
by the nutrition intake. For example, leptin plasma levels depend on meal time; irregular 
time of nutrient intake is a risk factor for the leptin resistance, a common finding in IR 
[71]. Pancreatic cell possesses self‐sustained circadian genes and protein oscillations of the 
transcription factors clock bmal1 [72]. PPARγ, a regulator of adipocyte differentiation and 
secretion and of insulin signal transmission, has circadian oscillations [73] but it is also ac‐
tivated by fatty acids. PGC1α coordinates genes in lipid and glucose metabolism, the PAI‐1 
promoter and the thrombocytes activation [30]. It is stimulated, in heart and liver, by fast‐
ing [74]. What are the specific interferences between the intrinsic oscillation of expression 
of these proteins and the environmental factors (mainly nutrition and light) are currently 
a subject of intense research.
Social and psychological factors are other important modifiers of sleep homeostasis and 
even of the pacemaker control, with specific markers at the cellular level. For example, in 
forced‐desynchrony experiments in which the sleep‐wake cycle and the associated fasting‐
feeding and dark‐dim light cycles are scheduled at a longer tau than 24 h, disrupted tran‐
scription of the clock genes expression, epigenetic modifications of chromatin, impairment 
of the RNA polymerase, modification of the regulation of transcription and translation of 
heat shock proteins and temperature‐sensitive RNA binding proteins (CIRBP and RBM3) 
have been recorded [55].
The higher weight gain of the night eating syndrome is another consequence of the desyn‐
chronization of the circadian rhythm. A plausible biological explanation is that the nutrient‐
induced stimulus is acting out of the phase of the physiologic oscillations of these proteins. 
If, for example, melatonin secretion is delayed, there will be a decrease time between wake 
time and circadian melatonin offset phase that will increase the eating behaviour. The modifi‐
cation of appetite could also be related to changes in ghrelin and leptin levels in short sleepers, 
significantly increasing BMI [75]. Changes in preference for salty or high carbohydrate foods, 
irregular meals and snaking behaviours [76] have also been reported.
3. Sleep disruption is well studied particularly in sleep apnea, but in this specific sleeping 
disorder the intermittent hypoxia was the core mechanism for the explanation of the 
majority of the cardio‐metabolic influences.
During the night shift, sleep disruption cannot be avoided. It certainly affects the quality of 
sleep and the sleep architecture (the proportion between REM and NREM cycles and their 
duration). Sleep (particularly REM cycles) activates transfer from the short‐ to long‐term 
memory and allows, from the occupational perspective, to integrate new tasks of the job; 
therefore, time to recovery is an important factor influencing the stress level and the employ‐
ees’ productivity. Response to meaningful stimuli is different during sleep: for example, a 
person will wake up to a lower voice stimulus while hearing his own name versus hearing 
someone else's name [77].
The irregular sleep‐wake cycle has been associated, in an ageing population, with higher car‐
dio‐vascular risk, independent of other risk factors. The metabolic consequences of frequent 
sleep disruption are similar to those of sleep deprivation.
Sleep latency may become problematic after frequent disruptions of the sleep and this affects 
the duration of sleep after the shift, acting in synergy with the short sleep duration.
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Clinical evaluation: Anamnesis should focus on the duration, difficulty in sleep initiation and 
on the napping habits. Complaints such as diminished intellectual performance, tiredness, 
loss of interest, reduced level of attention or concentration on tasks, increased number of mis‐
takes and work accidents should always raise the awareness about a possible sleep disorder. 
Dangerous habits, such as smoking, alcohol and auto‐medication for sleeping pills might be 
the clinical manifestation of the sleep problems.
In clinical practice, a structured interview is very helpful for all employees at risk. In general, 
the following items are investigated: bedtime (bedtime resistance, sleep onset delay), sleep 
behaviour (amount, snoring, leg movements, number of waking episodes) and morning wake 
up (time, self‐induced, sleepiness during the day). The sleepiness level, for example, can 
be evaluated using different scales. The extreme chronotypes are assessed with the Horne‐
Östberg morningness‐eveningness questionnaire [78]. The major items used in this question‐
naire are: time of getting up and of going to bed, level of alertness, the best interval during 
the day for occupational or recreational activities and the perceived difficulty to perform a 
certain activity at different hours. A sleep diary for a minimum 2 weeks is a very good tool for 
monitoring sleep duration, day or night distribution, weekly distribution, onset and wake up 
time. The non‐recuperated sleep debt might be the underlying cause of the complaints.
Determination of the specific sleep pattern (periodicity of sleep duration waxes and wanes) 
would be ideal for pacing the shifts. The maintenance wakefulness test is sometimes necessary 
to assess the ability to stay awake in soporific conditions (quietness, dim light, confortable 
temperature). It is measured using the polysomnography method under standard conditions 
[79] and is an objective measure of the inability of some patients to maintain normal alertness 
during the daytime.
The first step in any sleep disorder without organic substrates is to eliminate contextual fac‐
tors for the sleep latency or delayed sleep onset. Sometimes, just social adjustments or intro‐
duction of the basic recommendations for an efficient sleep routine will be enough (relaxing 
activities 1/2 h before going to sleep, avoid TV, computer screen light, avoid intense physical 
activities 3 h before going to bed, avoid caffeine containing beverages in the second part of the 
day, etc.). In other cases, avoiding shift work become mandatory, at least for a certain period 
of time, enough for recovery.
A special issue is related to the existing diabetes or cardio‐vascular disease that might be 
aggravated by this working schedule. In some countries, national regulations allow the occu‐
pational physician to demand the employer another kind of working time. Whenever this is 
possible, it seems to be the best option.
3.3. Stress
There are many definitions of stress. From the biological perspective, the process underlying 
stress is initiated by stressors and implies a stress‐response (bodily reaction to stress, both 
psychological and physical) that also creates an emotional impact. If this impact is emotion‐
ally positive, the perception is of a positive or motivational stress; the negative emotional 
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impact defines the distress. In response to chronic stressor stimulation, activation of the 
hypothalamic‐pituitary‐adrenal axis and of the sympathetic nervous system increases cor‐
tisol and adrenaline systemic levels, heart rate and blood pressure. These biological effects 
have been used to measure, objectively, the level of stress. Chronic high levels of counter 
regulatory hormones (cortisol and adrenaline) are a plausible biological explanation of the 
insulin resistance related to stress. Indeed, in individuals with metabolic syndrome, levels 
of cortisol metabolites and catecholamine are found significantly higher than in controls, 
with a reduced cardiac frequency variability related to the higher sympathetic tonus, and 
high levels of inflammatory markers (protein C and IL6); the psychosocial factors are esti‐
mated to explain around 13% of these effects [80]. Negative emotions have an acute impact 
on the inflammatory and vasoconstrictor tonus; an interesting comparison between acute 
myocardial infarction precipitated by a stressful event and the ones without a distinguished 
negative event showed a significantly higher monocyte chemoattractant protein‐1 (MCP‐1) 
and endothelin‐1 (ET‐1) in the first group [81]. Distress also influences the spontaneous indi‐
vidual strategies to cope with stress, leading to unhealthy behaviours such as smoking, bad 
nutrition, low physical activity and addictions [82].
Occupational stress is considered the second most common work‐related health problem, 
affecting 28–40% of the workforce [83, 84]. Several conceptual models have been developed 
to analyse the level of occupational stress. The theory of Karasek et al. based on the job 
demand and the control power or autonomy [85] focuses mainly on the personal control and 
short‐term stressors. Siegrist et al. [86] created a model based on the effort ‐reward balance, 
with more emphasis on social equity and on long‐term perspective [87]. A third model, the 
job demand‐resources model, has been proposed by Bakker and Demerouti [88], challeng‐
ing previous approaches for treating the diverse working conditions in a similar and general 
way; this model considers that even if job demands are relatively high, they will not generate 
distress if the organization provides the functional frame for achieving the goals, reducing 
by that the physical and psychological cost of the employee. Even if there are certain over‐
laps in these models, their focuses are different: while the Karasek et al.'s model focuses on 
the psychobiological impact on the threatened control, Siegrist et al. changed the accent on 
the threatened reward and Bakker and Demerouti have highlighted the threatened support.
In clinical research and practice, the measurement instrument of the perceived stress is 
the questionnaire. Depending on the conceptual model used, the items are different: for 
the first model, the quantity of work, the time constraints, the autonomy in making deci‐
sions, including the creativity and the possibility of skills development are the main items. 
The effort‐reward model uses questions to assess the time constraint, the responsibility, 
competitiveness and fairness of treatment inside the organization, the job promotion per‐
spectives, respect and esteem, job status, security of employment and external motivators 
(adequate salary). The demand‐resource model claims a specific analysis by the type of 
activity and organization resources and hence, there is no a general questionnaire pro‐
posed. These instruments have been enriched, in certain studies, with specific items related 
to sleep disorders, fatigue, sufficiency of recovery time, and posttraumatic stress (the psy‐
chological injury risk indicator) [89], and they continue to evolve, creating much difficulty 
in the comparison of data.
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Occupational stress is closely related to job dissatisfaction. Job satisfaction has a multitude of 
determinants, from job content, to values and leadership of the organization, management 
style (participative or authorship) and organizational culture (supportive or punitive, lead‐
ership role model, carrier paths definition, co‐worker support, salary benefits, recognition, 
work‐life balance, etc.). Nowadays, when competitiveness demands frequent improvements 
in the organization, proper change management processes became increasingly important in 
maintenance of the job satisfaction. Change is stressful if there is not enough planning, sup‐
portive leadership and if it is very frequent, creating the feeling of instability [90]. It is the 
management duty to find possibilities for job enrichment, job enlargement or job rotation in 
the process of change to increase the internal motivation and the meaningfulness of the job. 
But the rapid development of work and constant training create high pressure on employees 
and reduce family and recovery/recreational time, no matter how motivated the employee is. 
It can be only partially compensated, sometimes, by a perceived increase of the quality of fam‐
ily time through the actualization of the new skills in different social contexts.
Employees quit managers, not companies but they also leave if there is a misfit between their 
competencies and skills and the tasks and goals requested (poor recruitment process), if there 
is role ambiguity or too little decision power. Work time arrangements have several aspects 
in which the management of the organization can intervene to reduce stress and to increase 
job satisfaction and productivity such as shift work scheduling, number and flexibility of 
the work hours and overtime. By simply forward‐rotating the shift system, the mean num‐
ber of days on which the workers reported sleepiness, the heart rate at rest and the systolic 
blood pressure decreased significantly [91]. Longer working hours lead to increase in smok‐
ing, drinking and weight gain [92], affect the need to recovery time and create psychological 
distress [93]. The Karoshi phenomenon (‘death from overwork', in Japanese, associated with 
more than 60 h/work month) is rarely recognized as such in western societies [94], but the 
silent, progressive association between insulin resistance and stress might be, interpreted, in 
fact, as part of the same picture.
Particularly in services, flexibility in both time and location is a new way of working that 
shifts the organization from standard, repetitive procedures to project‐based short‐term activ‐
ities. In certain developed countries, such as Sweden, only 16% of jobs are regulated in terms 
of time, space, process flow and coordination, performance evaluation and peer interrelation, 
with differences between private (more flexibility) and public sectors, activity domains (ser‐
vices more than production) and gender: women more frequently employed in positions with 
higher levels of regulation than men [95]. Flexibility has certain advantages for stress reduc‐
tion: it fulfils the need for autonomy and decision empowerment and gives the employee the 
perception of the self‐determination of his working time, in terms of duration and daytime 
distribution. On the other hand, flexibility creates an opportunity for the employee to stay 
in a permanent ‘switch on’ work activity, predisposes to isolation, lack of supervision and 
peer support and reduces the development of the interpersonal skills and relations. These 
can lead to burnout or to unhealthy behaviours (e.g. snaking, increase consumption of sweet 
beverages, smoking) [96]. Family working balance is more and more important in dual‐career 
couple societies and effort recovery time and psychological detachment from work are central 
in maintaining this equilibrium.
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Relationship between IR and occupational stress: To answer this question, a comprehensive sys‐
tematic review [97] of the prospective studies linking stress and metabolic syndrome found 
a positive relation. Gender seems to be important in terms of stressors: for women, the main 
risk factor was job strain, whereas for men the feeling of justice at work was the main protec‐
tive factor. When assessing the individual components of the metabolic syndrome, weight 
gain was inconstantly associated with job stress, but low justice at work was associated with 
high triglycerides in men and job strain with high cholesterol in both sexes. Development of 
diabetes in men was in direct relation with higher demands. Job insecurity and low feeling of 
justice in men and effort‐reward imbalance in women were associated with an increased high 
blood pressure risk. Low effort and low engagement lead to increased dissatisfaction towards 
job and in medium term might lead to a certain degree of depression. At the opposite end, 
the low effort and low engagement are overcommitment and this attitude also amplifies the 
adverse health effects; overcommitment is expressed by a continuous thinking of work dur‐
ing the normal social/relaxing time, with an impossible switch off from work. From psycho‐
logical perspective, it underlies the need for approval and recognition at work [98]. The most 
frequent manifestations of overcommitment are burn out, psychological distress, musculo‐
skeletal complaints and self‐rated poor health [99, 100]. In a large Dutch study, overcommit‐
ment increased by more than 20 times the risk of emotional exhaustion in workers recording 
an imbalance between effort and reward compared to those without overcommitment [101].
Direct life‐threatening jobs (policemen, firefighters, sailors) are well‐known stressing condi‐
tions. Policemen has a high score in demand‐control‐support scale and in the effort‐reward 
imbalance scale and these scores could explain the more than doubled OR of metabolic syn‐
drome, particularly for the hypertriglyceridemia component [102, 103]. Working in confined 
spaces is another well‐recognized stressor: after only 5 months of sailing around the world, 
in a rather small ship with only 16 persons an equipage, BMI, HbA1C, basal insulinemia 
and triglyceride level [104] significantly increased. In these particular working conditions, the 
circadian rhythm modification, the changing working environment, the rapidity in decision 
process, the loss of control on own private life and private activities and the anxiety in front 
of unknown future conditions were considered as additional stressors.
But occupational stress does not require only extreme conditions. A large British study, includ‐
ing more than 10,000 civil servants, using the demand control evaluation method in repetitive 
measurements, concluded that more than 14 years of chronic stress exposure increases the 
risk of metabolic syndrome by two in men and by five in women [105].
If job might be stressful, nevertheless loosing job or job insecurity is another very stressful 
event. This association is supported by many studies [106–108]. Moreover, the relationship 
between the numbers of financial negative events in one's life was independently related to 
insulin resistance in a large, general population study in Finland [109].
Health risk factors (smoking, drinking, low physical activity, increased BMI) are more fre‐
quent in public sector employees perceiving low rewards or low occupational effort [89]. 
While low‐reward perception is intuitively link with dissatisfaction, low effort should 
be expected to generate the opposite; however, in a large‐scale meta‐analysis, it has been 
found that low effort and low engagement reduce the job satisfaction and increase the level 
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of depression [110]. These occupational stressors generate coping behaviours for the job in 
satisfaction and depression. However, in both prospective and cross‐sectional studies, the 
strength of the association could be minimized by the variety of individual reactions to stress, 
reducing the statistical significance for each behaviour.
Stress and nutrition relationship: As nutrition is so important in the insulin resistance phys‐
iopathology, the effect of stress on eating behaviours has been largely studied. In an ideal 
homeostatic balance, appetite and eating should be driven by the internal eating cues (hun‐
ger and satiety). But food is also a basic primary reward and in our food abundant modern 
society, numerous other external factors trigger eating. Emotional food choices are certainly 
influenced by the level of the stress hormones; other factors, such as gender, age and cultural 
modulates this behaviour. Female tends to be influenced more by the negative emotions. For 
example, in young women, binge eating has been related to executive function impairment 
such as cognitive impulsivity, insufficient planning and higher levels of cortisol release in 
relation to stressors. The tendency towards depression is also high among them [111]. On the 
contrary, men are increasing their portions, when experiencing positive emotions [112].
Stressed students and adolescents generally eat less healthy [113], and this attitude is also 
more influenced by negative emotions [33]; body image is the main concern [114] at this age 
that opposes the emotional food intake. Adults may improve emotion control and, in general, 
increase the health concerns about food; in this context, in healthy subjects, the positive emo‐
tions become more powerful in leading eating behaviour. Apparently, even liking for specific 
taste changes with age: salt liking increases and sweet taste decreases [115]. Emotional eating 
is frequently related to sweat taste liking that is more expressed in women [115, 116].
Stress and eating dysregulation or a poor differentiation between internal eating cues (hun‐
ger, hypoglycaemia) and external stressors are closely related and may be expressed in dif‐
ferent personalities either as overeating or as fasting. Eating dysregulation is more frequent 
in persons having difficulties of identification own feelings and emotions (alexithymia) [117]. 
High‐caloric foods (snacks) are convenient food for this type of behaviour; indeed, in experi‐
mental induced stress, people often consume more sweet fat foods than usually [118]. There 
is a biological explanation of this consumption, as such foods increase the serotonin level 
that improves mood. The mood improvement creates a positive, but medium‐ and long‐term 
unhealthy, feedback loop, that contributes to permanentize the behaviour. Emotional eating 
has been explained by inadequate parenting practices during childhood: an increase control 
and restriction of certain foods for fear of weight gain (the ‘dietary restraint model') or usage 
of foods to emotionally comfort (‘affective state model') are influencing the adult emotional 
eating and create a significant role for the food‐reward behaviour in adults [119]. Recent stud‐
ies highlighted the genetic role: an increased number of central dopaminergic receptor 2 and 
a melatonin receptor allele are a risk factor for emotional eating and energy intake under 
stressful conditions [120, 121].
Even if link between stress and insulin resistance seems to be well argued by the existing 
data, some limitations of these studies should be highlighted. The comparability and repro‐
ducibility of data are difficult because there are a variety of instruments used to measure 
stress. Another limitation is that most of these studies (particularly the large ones) are studies 
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from the public sector, and might not be fully transposed into the private sector, where com‐
petitiveness might be higher and job employment less predictable. Even less is known about 
small or family enterprises that have specificities in organization, human interrelation and 
high interference between family and occupational stress. Personal (non‐published) experi‐
ence with local small‐medium size firms showed that where there is tendency of preferred 
employment of relatives, there are additional stress factors, work inequities and general level 
of stress perception inside a firm.
Fortunately we still have large prospective studies confirming the risk between different com‐
ponents of the metabolic syndrome and stress perception. Even so, the methodology of these 
studies could be challenged: in many studies, there is no follow‐up of the drop off (quitting 
the job, for example, because of the high stress, weather there is a job demand/job control 
induced distress or an effort‐reward imbalance). If we would have the methodology to esti‐
mate in a proper way the healthy worker effect maybe the risk will be even higher, but this 
a common bias with all occupational risk hazards. When assessing the nutritional effect of 
job stress, almost all studies examined the increased in BMI and none have considered or 
measured the dual effect of job stress on increasing or decreasing weight. Hence, we cannot 
conclude whereas this would influence or not the final result.
Clinical approach: There are many types of questionnaires used to evaluate the level of stress. 
Selecting the most suitable instrument for an organization is sometimes difficult and involve‐
ment of psychologists and human resources specialists might be of great help. In individual 
assessment, the detailed anamnesis, the working time and the perceived complexity of job 
demands are more easily revealed during the consultation. As in other occupational medi‐
cine consultations, attention should be paid to repetitive group complaints that underline a 
common organizational problem. Collaboration with the line managers and human resource 
management in a stress reduction programme is essential.
Health status also influences the employment choice and the occupational specialist has a 
role in modulating this choice. For example, fatigue is one of the reasons people quit shift 
work and organic causes should not be omitted before claiming stress as the causative factor. 
Clinical examination and exchange of medical information with the general practitioner are 
beneficial in finding the best possible solution for the employee.
3.4. Chemical hazards and air pollution
Assessing the health impact of toxic exposure is an important part of the occupational medi‐
cine practice. During the past decades, industrial exposure to chemicals has been gradually 
reduced in many countries by better safety measures, but low level constant and long‐term 
exposure are still a matter of concern for many industrial and service workplaces. Occupational 
exposure to heavy metals occurs in many industries not only in the metal industry (mainly 
from electric air furnace or welding), metal refineries, battery production, colorant and pig‐
ment industries, smelter operations, radiator repair shops, mining, construction, but also in 
the modern days in the recycling industry and copying machine chambers. Indoor pollu‐
tion and environmental exposure (from drinking water, outdoor pollution) are other possible 
sources of particles and chemical exposure linked to insulin resistance.
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Heavy metals: Numerous studies indicated an association between heavy metals and insulin 
resistance (cardio‐vascular diseases and diabetes) [122–127] explained by their direct effects 
on ROS production and inflammatory mediated cellular and systemic damage, decreased 
mitochondrial function with reduction of the capacity for fatty acid oxidation, inhibition of 
lipoprotein lipase in adipocytes and β‐cells destruction [128]. Maternal gestational diabetes is 
also increased by heavy metal exposure [129].
Arsenic is well known for its carcinogenic, skin and neurological action. Arsenic epidemio‐
logical data about diabetes and cardio‐vascular effects is quite extensive and comes from 
very different countries, both developed and under developed ones [130, 131]. Industrial 
activity and drinking water are the major source of exposure [132]. In drinking water, levels 
higher than 150 mg/L are positively associated with diabetes. Lower drinking water levels 
gave contradictory results [133, 134] in different studies, most probably needing a longer 
term exposure to produce the negative health effects. Arsenic is a highly reactive metal. 
Inside hepatocytes, the methylation of arsenate and arsenite generates monomethylarson‐
ate (MMA) and dimethylarsinate (DMA), the latter being less reactive and more rapidly 
eliminated in urine. Metabolomics techniques revealed 103 urinary and 32 plasma metabo‐
lites associated with the urinary arsenic level. Interestingly, metabolites related to energy 
(ATP) production were common in diabetes and non‐diabetes individuals, although the 
energy generation is different at the cellular level, insulin is active or if there is an IR. There 
were also other compounds affecting the citric acid cycle or the amino acid metabolism 
that were specifically modified only in diabetes, supporting the influence of arsenic on the 
diabetes status [135]. Under moderate environmental arsenic exposure [136], high inor‐
ganic urinary As and urinary DMA excretion were associated with high diabetes incidence; 
higher MMA had an inverse effect. Experimental data also supports an action of DMA on 
adipocytes (reduction of the insulin signal) and on beta cells apoptosis. Exposure burden, 
the type of arsenic compounds but also polymorphisms of arsenic (III) methyltransferase 
gene (AS3MT) [137] are relevant for the relation between MMA and DMA and nutrition, 
particularly on folate intake.
In animal experiments, arsenic has many pathophysiological effects related to insulin resis‐
tance: it reduces the intracellular insulin signal by suppressing the expression and phosphory‐
lation of protein kinase B (PKB/Akt) and by direct inhibition of the Akt pathway [138]. Arsenic 
affects hepatic glucose output, increasing gluconeogenesis and up‐regulates genes involved 
in oxidative and inflammation processes. As other heavy metals, arsenic causes mitochondrial 
toxicity reflected by the decreased level of the mitochondrial deacetylase, of FOXO 3a, ionic 
transport and membrane potential, decreased activity of manganese superoxide dismutase 
and increased reactive oxygen species [139]. Arsenic activates stress sensitive signalling path‐
ways initiating pancreatic cell apoptosis [140] and oxidative stress in liver cells [141]. Arsenic 
has also a pro‐thrombotic action and acceleration of atherosclerosis explaining the cardio‐vas‐
cular effects [142, 143].
Mercury (Hg): Cross‐sectional and prospective studies showing increases prevalence of 
diabetes [144, 145] in people exposed to Hg, which are not confirmed by others [146]. Hg 
is a very reactive metal: it interacts with the ‐SH groups of different enzymes, antioxidants 
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(glutathione), and even with amino acids. Substantial experimental data concluded that 
Hg has both direct pro‐oxidant effects and a capacity to reduce the antioxidant defence 
mechanism [147]. These characteristics have been confirmed in high occupational exposure 
[148, 149]. Hg reduces gluthatione, superoxide dismutase, catalase and thioredoxin reduc‐
tase [150]. Denaturation of proteins increases the endoplasmic reticulum stress, initiating 
apoptosis. The inflammatory status is materialized by the increased levels of IL4, IL6, IL7 
and TNFα and IFNγ [150]. Apart from these systemic effects, Hg has also more specific 
effects related to IR development: Hg has a direct toxic, pro‐apoptotic effect on β‐cells 
[151]; it decreases the insulin effects [152] and induces apoptosis in adipocytes.
Other heavy metals have also been involved in metabolic inflammation. During the cellular 
immune response, it was demonstrated that radicals induced by lead (Pb) disrupt the tran‐
scription signalling pathway mediated by the mitogen‐activated protein kinase, nickel (Ni) 
induces the NLRP3‐ASC‐caspase 1 and As induces tyrosine kinase Src. The nuclear factor 
kB is activated by Pb, Ni or Hg with an increase in gene transcription for early inflammatory 
cytokines, such as Interleukin 1, interleukin 6 and tumour necrosis factor. Some metals, such 
as cadmium (Cd), can activate an inflammatory response through tissue damage induction 
mediated by free radicals, which results in leukocyte recruitment and cytokine secretions. 
Inflammation generated by metals can be reduced by metallothionein that has the ability to 
scavenge free radicals and bind toxic metals through the release of Zn and oxidation of SH 
groups [153].
From my previous personal clinical experience, in the Occupational Medicine Clinic of the 
Colentina University Hospital in Bucharest, I can confirm that workers from a lead battery 
factory, currently closed, admitted with saturnine colic, that had heavy Pb exposure, pre‐
sented almost constantly a reversible hypertension syndrome.
Heavy metals and smoking: Smoking habit is one of the most important sources of cadmium 
in the general population. In fact, reduction of cadmium levels in the general population 
has been attributed to the efficiency of the anti‐tobacco campaigns and policies [154]. Lead, 
nickel and chromium are also found in the tobacco smoke at significant levels. The relation‐
ship between smoking and diabetes is grounded on large epidemiological studies [155, 156]. 
Mechanisms such as impaired peripheral glucose uptake, oxidative stress, metabolic inflam‐
mation [157], and retention of the inhaled high concentration of metals (As, Al, Cd, Ni, Hg 
and Pb) [158, 159] have been described. A synergic effect of occupational exposure and smok‐
ing was found in smelters [160] or mining workers [159]; the common proposed pathological 
mechanism is the reduction of the anti‐oxidative defence [160] or the increased retention of 
the heavy metals.
Other toxicants: Epidemiological studies brought the attention on other environmental 
toxicants such as persistent organic pollutants (POP), endocrine disruptors, or substances 
involved in the toxic oil syndrome (presumably aniline). POP is a generic term for a variety 
of chloride or bromide compounds, including pesticides and dioxin. Longitudinal studies 
showed that persons with high basal level of blood POP are at increased risk for diabetes. 
Studies that have also monitored the PCB were able to exclude the non‐reverse effect of 
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diabetes [161]. The stronger evidence of these associations came from occupational exposure 
studies: high accidental environment contamination [162] increased the relative risk of dia‐
betes and of cardiovascular disease. Non‐accidental occupational exposure in cohorts from 
12 different countries also confirmed the relationship [163]. Bisphenol A is also a POP, well 
known for its endocrine disruptor effects; besides other negative effects, the rate of gesta‐
tional diabetes is increased in women with a higher blood level [164]. Toxic oil syndrome‐
registered patients have threefold increase in prevalence of diabetes, and higher incidence of 
metabolic syndrome [165, 166].
The intimate mechanism of these associations is not completely found and most probably has 
certain specificities according to the particular substance. Many pathological pathways have 
been implicated: the increased accumulation of abdominal fat [167], inflammatory markers 
[168], adipocyte cytokines, TNFα and nuclear transcription factor kappa B (NFκB) [47], uric 
acid [169]. As a direct effect on the insulin signal, in animal experiments, perfluorooctane sul‐
fonate inhibits the insulin Akt, signal leading to insulin resistance [170].
Particulate exposure: Air pollution, particularly fine and ultrafine particles, has been related 
to the acute incidence of cardio‐vascular events and asthma attacks from inflammatory, 
oxidative mechanisms and pro‐thrombotic mechanisms activation [171]. This correlation 
remained consistent after exclusion of possible confounders (education level, work expo‐
sure, alcohol, vegetable and fruit consumption, smoking or physical activity) [172]. Initially 
described for cardiovascular effects [171, 173], the particulate exposure includes now 
also the increased risk for diabetes [174, 175] and for non‐alcoholic steatohepatitis [176]. 
Particulate matter (PM) is generally a subject of environmental health, and exposure during 
the day is very variable depending the microenvironment (home, kitchen, policy of smok‐
ing indoor, traffic, general level of city pollution control, occupation) [177]. However, there 
are also many workplaces were PM10 (the respirable component), PM2.5 (fine particles) 
and the PM0.1 (ultrafine particles) have still high values. Road transport, energy production 
and distribution, waste as well as domestic exposure (cooking) are major sources in Europe 
[178]. Photocopiers centres, sick buildings might also have PM10 and PM2.5 above than 
permissible levels.
Large cohort studies in North America showed that a 10 g/mm3 increase in PM2.5 was associ‐
ated with 13% increases in hypertension and with 18% increase in diabetes‐related mortality, 
concluding that current PM 2.5 US standards are too high for the long‐term exposure and 
should be reduced [179].
In different countries or regions, the proportion and the composition of air pollution differ; 
in a China study, fine particles bound polycyclic aromatic hydrocarbons (PAH) and this char‐
acteristic might have a cumulative effect on IR, as it has independently associated with this 
risk [180]. PAH is an environmental pollutant but exposure is increased in occupations that 
involve bitumen and asphalt manipulation, in foundries, distilleries, painting industry and 
other manufactories [181, 182]. Firefighters are also exposed to significant levels. Smoking is 
another important PAH source and, therefore, efforts to reduce this habit in workers occupa‐
tionally exposed are highly recommended.
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The particulate matters IR pathophysiologic mechanisms are rather similar to the ones involved 
in heavy metal exposure: obesity risk increase [183], enhancement of inflammation, with higher 
plasma levels IL8, ICAM‐1 or eosinophilic cationic protein [184], endoplasmic reticulum stress 
and insulin signalling interference in a dose‐response manner [172]. Reduction in antioxidant 
defence is supported by both experimental on cell lines and from the increased effect on per‐
sons with GSTM1 null alleles [184]. Disruption of metabolic genes has also been reported [185]. 
Several studies proposed a link between genetic variants of ABO locus; particulate exposure 
and IR risk [186]. When occupational exposure to particles (particularly to asbestos, weld‐
ing fumes, respiratory irritants) was added to the epidemiological model, the risk of group 
O subjects was enhanced [187]. There is no conclusive explanation about this association, but 
ABO antigens are expressed also on the von Willebrand factor, presumably increasing the pro‐
thrombotic and chronic inflammation risk [188] and the ABO locus is related to the E‐selectin, 
ICAM‐1 and TNF‐α blood level [186].
Cardio‐vascular and ECG modifications: Controlled particulate exposure showed high sys‐
tolic [189] (or high systolic and diastolic increase [172] according to the type of particle), 
decreased of blood plasminogen and thrombomodulin, and an increase in the inflamma‐
tory markers: CRP and serum amyloid [190]. Diesel exhaust double‐blind experiment mean 
peak effect on systolic blood pressure increases between 30 and 60 min. after exposure and 
remained high 24 h after, independent of metabolic syndrome previously existing compo‐
nents. Interestingly, in this experiment, the increase in blood pressure was not related to 
perception of exposure [189]. Persons with metabolic syndrome exposed to ultrafine par‐
ticles and GSTM1 null allele are particularly at risk of altered repolarization and increased 
QT duration [191].
Clinical approach: Indoor air pollution measurement is part of the occupational safety pro‐
cedures and whenever data are available there should be transmitted to the occupational 
physician. The detailed occupational anamnesis, symptoms, clinical examination and existing 
exposure indicators orient the medical conduct.
For heavy metals exposure, biological monitoring is recommended in workplaces or occu‐
pations at risk. The biological monitoring is included in the national recommendations for 
occupational medicine practice in many countries. The limit values of the exposure indicators 
are defined for chronic poisoning. On what concerns the metabolic risk, there is no threshold 
limit established yet and general population data suggest that lower limits than those for 
chronic poisoning would be a reasonable approach. We cannot conclude this topic, until well‐
designed studies to address this specific objective are conducted. On the other hand, until 
these studies are available and taken into consideration the increasing incidence of insulin 
resistance worldwide, efforts to reduce this non‐classical risk factor should not be postponed.
A special concern is related to the maternal and foetal risk and to the gestational diabetes. 
Ideally, pregnant women should not be exposed to chemicals; if environmental contamina‐
tion is not easy to avoid, at least the occupational one should be limited. Besides the negative 
effects of chemicals on the foetus development, the increased risk of gestational diabetes adds 
unfavourable short‐ and long‐term consequences.
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4. Workplace interventions
As insulin resistance implication is better understood, and its prevalence increases worldwide, 
the number of interventions that have been published in last decade has also increased. Most 
of them, even if they directly target insulin resistance are better known as workplace wellness 
programmes. In countries were private insurance is paid by the employer, they could be a 
mean to reduce the insurance plans; in others, where work‐promotion activities are more and 
more valued by the companies, they are conducted either as a channel to encourage individu‐
als to take preventive measures through education and screening or as employment‐based 
activity to promote health behaviours and disease management, such as stress management, 
adjustable work station to reduce continuous sitting, team support groups and cafeteria/can‐
teen provision of healthy food initiatives. Although very diverse, there are however some 
general characteristics of these interventions:
1. Assessment of the health risk according to the working conditions. Risk assessment is always 
the first step as the intervention has to be meaningful for the organization and should 
reflect the specific issues of the employees. Working conditions and health‐related habits 
should be analysed, as multi‐component interventions have given better results [160]. 
Sometimes, just screening programmes initiated inside the company increase awareness 
and initiate individual actions [161]. In works with high aerobic workload, a low cardio‐
vascular fitness is a physical risk factor and a stressor. Increasing the aerobic fitness by 
initiating an exercise training programme was able to decrease the basal heart rate, the 
BMI and the inflammatory markers (high sensitivity protein C), to increase work effi‐
ciency and to reduce stress related to work overload. Sedentary behaviour has benefited 
from different ergonomically interventions [162, 163]. Some studies have emphasized the 
benefit of sitting interruption during the working day; efficiency of short 1–2 min every 
half hour of sitting break was better in terms of metabolic syndrome criteria compared 
to the two 15 min breaks per workday [164]. In certain circumstances, cumulative risk 
factors are encountered: for example, seafarers are recognized as a profession with high 
incidence of metabolic syndrome. An intervention including healthy cooking training 
for ship cooks together with improvement of the ships fitness facilities and education 
(anti‐smoking, individual exercise, extra health checks) led to a decrease in sugar intake, 
increased physical fitness scores and a significantly decrease in prevalence of the meta‐
bolic syndrome [165, 166].
2. Obtaining the maximum support of the management team. These interventions are changing 
behaviour interventions; they imply not only financial cost but also time allocation, orga‐
nizational changes, etc. If management is not convinced and does not actively supports 
the programme, making it part of the organizational culture, the chance of achieving the 
proposed results is considerably reduced. Presenteeism, defined as being present at work, 
but with a limited performance in some aspects of job related a health problem, is often 
a high hidden cost for employers. Improving the general health status and well‐being of 
their employees could be, therefore, perceived as a valuable investment. Stress manage‐
ment programmes, in particular, need specific organizational behaviour  assessment and 
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a proactive participation of the line and human resource management. Of course, there 
are some universally interventions for mental health [167], but they should be aligned 
with other managerial and organizational initiatives [168].
3. Proper preparation and communication inside the company: Ideally, some representatives 
of the beneficiaries should be involved in preparation of the intervention, for present‐
ing their needs and for choosing from different possibilities of implementation the best 
suited for them. Communication of the aim, the means and the expected results is neces‐
sary before, during and after the intervention. It is reasonable to consider that employ‐
ees are in different stages of motivation for change. Therefore, stage‐based intervention 
for non‐intenders, intenders and actors (people who have already taken action towards 
changing behaviour) could be more effective [169, 170]. Barriers to adherence and com‐
pletion of the programme are better solved in a participatory approach [171].
4. Adapted tools: There is no one solution for all organizations. For some, the online sup‐
port is possible and is part of their working culture; in other organizations, group or 
individual discussions are more effective. Computer‐based interventions have a better 
reach, particularly in larger organizations. A Cochrane systematic review on interactive 
computer‐based interventions for weight loss or weight maintenance in overweight or 
obese people found that such interventions significantly reduced body weight [172]. 
Combined systems with face‐to‐face and computer/telephone interactions are also used.
5. Team work, from the first steps of design until results evaluation. Nobody can 
expect that a transformational change can be proposed and delivered solely by 
the occupational physician, but it is desirable that he is an active member of the 
team [173]; psychologists, ergonomists, nutritionists, exercise trainers, IT and 
communication specialists, etc. are needed, according to the scope of the inter‐
vention. Concerning risk reduction of the metabolic risk, nutrition is a tradi‐
tional risk factor for insulin resistance and trained dieticians should be involved. 
Nutrition knowledge make people less likely to be hypertensive compared to one 
with low level of healthy nutrition [174] and when combined with a physical activity 
programmes [175], and facilitated access to healthy food, become more effective [176]. 
Workplaces are excellent settings for health promotion programmes, joining all these 
conditions together, if there is managerial commitment and support.
5. Conclusions
The minimum requirements for a health issue to become an occupational medicine subject are 
a proven relation with the working conditions, and a benefit from a working place interven‐
tion. This chapter had provided arguments that insulin resistance has both characteristics. It 
has, however, a specificity, that in some countries had brought benefits for including it in the 
occupational services and in others have been an obstacle: insulin resistance shares both ele‐
ments of the classical health protection and of the health promotion activities.
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In terms of health protection, insulin resistance is related to medium or even low exposure 
to air pollution (particles, solvents) or heavy metals. The biological monitoring reference 
for insulin resistance is not yet defined, making difficulties in interpreting field data. Using 
the general population assessments might be a solution, but there is clearly a need for well‐
designed research in this area to reach a valid conclusion. Insulin resistance is also related to 
other work hazards: work schedules, sedentary behaviour and stress. Concerning the work 
schedules, we benefit of many data, experience and general recommendations about working 
on shifts; flexible working time is a new challenge and probably needs more individual solu‐
tions. Occupational stress is recognized as one of the most important risk factor of the modern 
society and, even if it is more in the occupational psychology field, it has to be integrated in the 
occupational medicine service, as many other medical conditions, except insulin resistance, are 
aggravated by stress.
In terms of health promotion, prevention of insulin resistance and its major consequences 
(the cardio‐vascular disease and type‐2 diabetes) are perceived as part of the healthy life‐
style and well‐being programmes. Healthy nutrition, smoking cessation, physical activity and 
sleep hygiene are the pillars of these programmes. The appropriate and culturally adapted 
design increases the adherence to these programmes; their real success is the integration of 
the healthy behaviours and the reduction of obesity and insulin resistance‐related mortality. 
Management support is needed in the preliminary phases (approving and promoting the 
programme) but also during the implementation phase, as many of these activities request 
working condition adaptations. Better employee engagement is obtained by involving them 
from the early steps of the programme.
Therefore, assessment of the risk, screening and workplace intervention programmes to reduce 
insulin resistance incidence are part of the occupational medicine activity and should be included 
in the occupational health service provision. Further research to develop tools for on appropri‐
ate individual and organizational assessment and strategies for interventions is needed.
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